Woongjin Co., Ltd. (KRX:016880)
2,055.00
-95.00 (-4.42%)
At close: Aug 21, 2026
Woongjin Revenue
Woongjin had revenue of 342.32B KRW in the quarter ending June 30, 2026, with 22.77% growth. This brings the company's revenue in the last twelve months to 1.28T, up 26.20% year-over-year. In the year 2025, Woongjin had annual revenue of 1.15T with 14.14% growth.
Revenue (ttm)
1.28T
Revenue Growth
+26.20%
P/S Ratio
0.12
Revenue / Employee
1.38B
Employees
928
Market Cap
159.71B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.15T | 142.58B | 14.14% |
| Dec 31, 2024 | 1.01T | -10.47B | -1.03% |
| Dec 31, 2023 | 1.02T | -31.26B | -2.98% |
| Dec 31, 2022 | 1.05T | 69.98B | 7.14% |
| Dec 31, 2021 | 979.87B | 93.63B | 10.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| KG Chemical | 9.37T |
| Kolon | 5.99T |
| Samyang Holdings | 3.45T |
| HS HYOSUNG | 1.41T |
| KPX Holdings | 1.18T |
| Hyundai Futurenet | 268.71B |
| Singsong Holdings | 193.46B |
| Aprogen Medicines | 127.54B |